Atherosclerotic Cardiovascular Disease trials recruiting in Alabama

Fewer than 3 recruiting trials found.

All Atherosclerotic Cardiovascular Disease trials nationally

Cities in Alabama

Recruiting trials in Alabama

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female) · Alabama: Daphne, Fairhope, Huntsville, Mobile
• Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure
  NCT06962488 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female) · Alabama: Birmingham